Kernen, Germany

Karl-Ernst Schuster

This inventor holds 3 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1979-1981.


% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1979-1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Karl-Ernst Schuster

Introduction

Karl-Ernst Schuster is a notable inventor based in Kerken, Germany. He has made significant contributions to the field of photopolymerization and radiation-hardenable binders. With a total of 3 patents, Schuster's work has had a considerable impact on the development of advanced materials.

Latest Patents

Among his latest patents are innovative compounds such as Aryl-glyoxyloyloxyalkylacrylates, which are utilized in photopolymerizable applications. These compounds are essential for initiating the photopolymerization of monomers, leading to the production of high-quality polymeric coatings. Another significant patent involves radiation-hardenable binders based on thio-polyols, which consist of a reaction product that enhances the performance of various materials.

Career Highlights

Karl-Ernst Schuster is currently employed at Bayer Aktiengesellschaft, a leading global company in the chemical and pharmaceutical sectors. His work at Bayer has allowed him to explore and develop innovative solutions that address industry challenges.

Collaborations

Throughout his career, Schuster has collaborated with esteemed colleagues, including Hans J. Rosenkranz and Hans Rudolph. These partnerships have fostered a creative environment that has led to groundbreaking advancements in their respective fields.

Conclusion

Karl-Ernst Schuster's contributions to innovation in photopolymerization and radiation-hardenable materials highlight his expertise and dedication to advancing technology. His patents and collaborations continue to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…